Transcription of IMWG ガイドライン 多発性骨髄腫におけるサリドマイド／レナリドミド投与に関連する血栓症予防 骨髄腫の患者は、がん ...
1 imwg : ---------------------------------------- ---------------------------------- imwg VTE % 2 VTE o BMI30kg/m2 o VTE o o o o
2 O o VTE VTE 1 81 325mg 1 1 2 LMWH 40mg1 1 2 3 LMWH 40mg1 1 2 3 VTE o o / o MPT LMWH o + LMWH o + o VTE o o + 1 o LMWH VTE o o + o VTE o VTE compression ultrasonography o CT PE o CT CT pulmonary angiography Magnetic resonance pulmonary angiography o o DVT LMWH 5
3 INR 2 LMWH 1A Palumbo et al. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2008); 22: 414-423. 2JW Blom et al. Malignancy, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005); 293: 715-722. IMF
